Gary Blick

1.8k total citations
36 papers, 732 citations indexed

About

Gary Blick is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Virology. According to data from OpenAlex, Gary Blick has authored 36 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Virology. Recurrent topics in Gary Blick's work include Hormonal and reproductive studies (13 papers), HIV Research and Treatment (11 papers) and HIV/AIDS drug development and treatment (11 papers). Gary Blick is often cited by papers focused on Hormonal and reproductive studies (13 papers), HIV Research and Treatment (11 papers) and HIV/AIDS drug development and treatment (11 papers). Gary Blick collaborates with scholars based in United States, United Kingdom and New Zealand. Gary Blick's co-authors include Harvey Kushner, Martin Miner, Rajib Bhattacharya, Mohit Khera, Dat Nguyen, Una Hopkins, Mark Whiteside, Gerard J. McGarrity, Andrew Zolopa and Laurent Humeau and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and The Journal of Urology.

In The Last Decade

Gary Blick

35 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Blick United States 17 286 202 187 159 129 36 732
Chanel Avenant South Africa 13 100 0.3× 63 0.3× 88 0.5× 40 0.3× 21 0.2× 24 529
Caroline Dupont France 12 44 0.2× 362 1.8× 76 0.4× 230 1.4× 14 0.1× 27 897
Thomas H. Teal United States 14 51 0.2× 265 1.3× 232 1.2× 15 0.1× 9 0.1× 17 968
Vinicius Albuquerque Sortica Brazil 12 36 0.1× 99 0.5× 150 0.8× 24 0.2× 13 0.1× 25 809
Michael F. Murray United States 14 43 0.2× 80 0.4× 585 3.1× 187 1.2× 6 0.0× 23 1.2k
Sang‐Kuk Yang South Korea 13 86 0.3× 85 0.4× 152 0.8× 5 0.0× 23 0.2× 50 768
Michael Weigel Germany 10 64 0.2× 153 0.8× 94 0.5× 26 0.2× 6 0.0× 32 504
Giulia Calenda United States 12 31 0.1× 72 0.4× 71 0.4× 74 0.5× 6 0.0× 22 371
Mina Suzuki Japan 14 59 0.2× 88 0.4× 120 0.6× 23 0.1× 4 0.0× 30 589
Geetha Mylvaganam United States 14 71 0.2× 109 0.5× 71 0.4× 311 2.0× 22 0.2× 18 736

Countries citing papers authored by Gary Blick

Since Specialization
Citations

This map shows the geographic impact of Gary Blick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Blick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Blick more than expected).

Fields of papers citing papers by Gary Blick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Blick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Blick. The network helps show where Gary Blick may publish in the future.

Co-authorship network of co-authors of Gary Blick

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Blick. A scholar is included among the top collaborators of Gary Blick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Blick. Gary Blick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, Stefan, Gary Blick, Douglas G. Ward, et al.. (2024). Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study. Infectious Diseases and Therapy. 13(4). 891–906. 3 indexed citations
2.
3.
Laking, George, et al.. (2016). Mind the gap: An analysis of foregone health gains from unfunded cancer medicines in New Zealand. Seminars in Oncology. 43(6). 625–637. 9 indexed citations
4.
Albritton, Tashuna, et al.. (2015). Exploring Social Networking Technologies as Tools for HIV Prevention for Men Who Have Sex With Men. AIDS Education and Prevention. 27(4). 298–311. 22 indexed citations
5.
6.
Miner, Martin, Rajib Bhattacharya, Gary Blick, Harvey Kushner, & Mohit Khera. (2013). 12-Month Observation of Testosterone Replacement Effectiveness in a General Population of Men. Postgraduate Medicine. 125(2). 8–18. 22 indexed citations
7.
McGarrity, Gerard J., David Stein, Gary Blick, et al.. (2013). Patient monitoring and follow‐up in lentiviral clinical trials. The Journal of Gene Medicine. 15(2). 78–82. 89 indexed citations
8.
Blick, Gary, Mohit Khera, Rajib Bhattacharya, Harvey Kushner, & Martin Miner. (2013). Testosterone Replacement Therapy in Men With Hypogonadism and HIV/AIDS: Results From the TRiUS Registry. Postgraduate Medicine. 125(2). 19–29. 9 indexed citations
9.
Bhattacharya, Rajib, et al.. (2012). Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clinical Interventions in Aging. 7. 321–321. 24 indexed citations
10.
Blick, Gary, Mohit Khera, Rajib Bhattacharya, et al.. (2012). Testosterone Replacement Therapy Outcomes Among Opioid Users: The Testim Registry in the United States (TRiUS). Pain Medicine. 13(5). 688–698. 32 indexed citations
11.
Bassichis, Benjamin A., Gary Blick, Marcus A. Conant, et al.. (2012). Injectable Poly-l-Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open-Label Study (FACES). Dermatologic Surgery. 38(7). 1193–1205. 15 indexed citations
12.
Khera, Mohit, Rajib Bhattacharya, Gary Blick, et al.. (2011). The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). The Aging Male. 15(1). 14–21. 42 indexed citations
13.
Bhattacharya, Rajib, Mohit Khera, Gary Blick, et al.. (2011). Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocrine Disorders. 11(1). 18–18. 55 indexed citations
14.
Miner, Martin, Mohit Khera, Rajib Bhattacharya, Gary Blick, & Harvey Kushner. (2011). Baseline Data from the TRiUS Registry: Symptoms and Comorbidities of Testosterone Deficiency. Postgraduate Medicine. 123(3). 17–27. 17 indexed citations
15.
Cohen, Calvin, Daniel S Berger, Gary Blick, et al.. (2009). Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial. AIDS. 23(3). 423–426. 23 indexed citations
16.
17.
18.
Lori, Franco, Richard B. Pollard, Lucia Whitman, et al.. (2005). Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency. AIDS Research and Human Retroviruses. 21(4). 263–272. 9 indexed citations
19.
Blick, Gary, et al.. (1998). Successful Resolution of Progressive Multifocal Leukoencephalopathy After Combination Therapy with Cidofovir and Cytosine Arabinoside. Clinical Infectious Diseases. 26(1). 191–192. 49 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chanel Avenant Breakdown of academic impact, for papers by Caroline Dupont Breakdown of academic impact, for papers by Thomas H. Teal Breakdown of academic impact, for papers by Vinicius Albuquerque Sortica Breakdown of academic impact, for papers by Michael F. Murray Breakdown of academic impact, for papers by Sang‐Kuk Yang Breakdown of academic impact, for papers by Michael Weigel Breakdown of academic impact, for papers by Giulia Calenda Breakdown of academic impact, for papers by Mina Suzuki Breakdown of academic impact, for papers by Geetha Mylvaganam
Rankless by CCL
2026